May 3, 2024
Watch this special briefing featuring Vicente LLP leaders who have been deeply immersed in the federal scheduling issue, along with Mitzi Keating, a CPA and partner at Citrin Cooperman.
By Jason Adelstone
Apr 29, 2024
After listening to the House Oversight and Accountability Committee Hearing with the Commissioner of the FDA on April 11, one conclusion was reinforced—opponents of marijuana reform are misinformed and rely on misstating facts to support their position. Those against moving marijuana into schedule III are making their voices heard, but almost universally, those voices simply do not understand what schedule III would mean.
By Andrea Golan, Genevieve Meehan
Apr 1, 2024
For years, the efficacy of cannabis lab test results has been widely discussed across the California cannabis industry due to inflated potency test results and inconsistencies in results due to labs using different methodologies for testing cannabis. This has changed with the implementation of lab testing standardization.
By David M. Ullian, Tim Callahan
Mar 7, 2024
This Insights post provides an overview of recent changes impacting Massachusetts cannabis businesses. We break down the new Model Host Community Agreement (HCA), explaining its purpose, usage, and accessibility. Additionally, we explore the updated application and renewal processes, highlighting the mandatory inclusion of compliant HCAs or waivers. This blog serves as a valuable resource for both new and existing cannabis businesses seeking to navigate the evolving regulatory landscape in Massachusetts.
By Jason Adelstone
Jan 30, 2024
On August 29, 2023, the Department of Health and Human Services (“HHS”) sent the Drug Enforcement Administration (“DEA”) its recommendation to move marijuana from Schedule I to Schedule III of the Controlled Substances Act (“CSA”). Since then, the marijuana industry has waited in suspense for the DEA to make the final call as to what schedule marijuana will be placed. Read this Insights post that outlines the complex process of marijuana rescheduling in the US and outlines the key steps involved, from rule publication to review and final rule, emphasizing the critical role of stakeholder engagement in securing a Schedule III classification.
Nov 2, 2023
Watch as panelists address the current lab testing and compliance issues in the industry, testing standards across the country, and the importance of reliable testing.
By David M. Ullian, Gabriel Amatruda
Oct 5, 2023
Public support for medical cannabis in North Carolina is quite strong and despite being one of only a few states that have legalized medical or adult use, cannabis is finally making headway in the Tar Heel State. Read this article to learn about recent cannabis and hemp developments in NC, including legislation and the Eastern Band of Cherokee Indians’ vote to legalize adult-use cannabis.
Oct 4, 2023
Watch this special briefing where Vicente LLP leaders share insights on the impacts of the HHS recommendation to reschedule cannabis and outline the road ahead.
Sep 21, 2023
Join Casey Leaver and Stephen Pemberton at the Cannabis Quality Conference on October 18! Casey and Steve will discuss creating a culture of compliance to help your cannabis operation thrive.
By Andrea Golan
Aug 23, 2023
Minnesota's new adult-use cannabis law makes some significant changes to the state's existing rules governing the manufacture and sale of hemp-derived cannabinoid products. Read this article for information on some of the most notable changes, including seller registration requirements, prohibited products, and cannabinoid serving limits.
Aug 17, 2023
So, you received your provisional Connecticut cannabis license or just renewed your final license. Now what? It’s time to get on the path to success as an operational and compliant cannabis operator.
By Genevieve Meehan, Emily Hackman
Jul 26, 2023
As cannabis markets mature, regulatory agencies typically increase compliance enforcement through inspections and audits. It has become increasingly clear that The Oklahoma Medical Marijuana Authority has shifted toward increased and escalated enforcement and heightened license application scrutiny. Learn more about this shift and review the updated OMMA inspection forms by reading this Insights article.
Jun 28, 2023
Watch this Vicente LLP session, where cannabis training and compliance experts from Vicente, Cannabis Trainers and Rootwurks will discuss the gold standards for cannabis employee training and the most common (and costly) compliance pitfalls they’ve seen across the industry.
By Casey Leaver
Apr 10, 2023
The Massachusetts cannabis employee data breach made public last month by the Cannabis Control Commission, combined with recent announcements about the Commission’s “secret shopper” program and an increase in unannounced inspections at licensed facilities, presents a trifecta of reminders for marijuana establishments to revisit their standard operating policies and procedures (SOPs).
By Shane Pennington
Nov 9, 2022
What outcomes are possible from the impending administrative process to reconsider cannabis’s schedule I status? What are the implications of those various possible outcomes? And how should we all proceed in light of it all?
By Shane Pennington
Oct 21, 2022
To appreciate the gravity of the President’s scheduling directive and what could happen next, you need to understand (1) how the administrative process the President has set in motion will actually work and (2) how the agencies in charge have used it to affirm and reaffirm cannabis’s schedule I1 status repeatedly throughout the Comprehensive Drug Abuse Prevention and Control Act of 1970’s (“CSA”) history. Those topics are covered in this article.
By Jennifer Flanagan
Aug 26, 2022
Jennifer Flanagan writes for the Worcester Telegram & Gazette, reflecting on the Commonwealth's first major cannabis reform legislation since Massachusetts established a regulated adult-use cannabis market.